Pneumococcal Conjugate Vaccine Safety in Elderly Adults
Hung Fu Tseng(Kaiser Permanente), Steven J. Jacobsen(Mayo Clinic), Lisa A. Jackson(Kaiser Permanente Washington Health Research Institute), Lina S. Sy(Kaiser Permanente), In-Lu A. Liu(Kaiser Permanente), Sara Y. Tartof(Kaiser Permanente), Nicola P. Klein, Jennifer C. Nelson(Kaiser Permanente Washington Health Research Institute), Elizabeth Liles(Kaiser Permanente Center for Health Research), Edward A. Belongia(Marshfield Clinic), Lei Qian(Kaiser Permanente), Eric Weintraub, Bruno Lewin(Kaiser Permanente), Cheryl Mercado(Kaiser Permanente), Matthew F. Daley(Kaiser Permanente)
Cited by 23
Related Papers
Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans
|Science|2009|2.5k
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
|The Lancet Infectious Diseases|2011|1.8k
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
|The Lancet|2021|1.3k
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
|New England Journal of Medicine|2021|937
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720